FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008990589> ?p ?o ?g. }

• W2008990589 endingPage "1363" @default.
• W2008990589 startingPage "1353" @default.
• W2008990589 abstract "Sensitive method for chemical analysis of free cholesterol (FC) and cholesterol esters (CE) was developed. Mouse arteries were dissected and placed in chloroform-methanol without tissue grinding. Extracts underwent hydrolysis of cholesteryl esters and derivatization of cholesterol followed by liquid chromatography/mass spectrometry (LC/MS/MS) analysis. We demonstrated that FC and CE could be quantitatively extracted without tissue grinding and that lipid extraction simultaneously worked for tissue fixation. Delipidated tissues can be embedded in paraffin, sectioned, and stained. Microscopic images obtained from delipidated arteries have not revealed any structural alterations. Delipidation was associated with excellent antigen preservation compatible with traditional immunohistochemical procedures. In ApoE−/− mice, LC/MS/MS revealed early antiatherosclerotic effects of dual PPARα,γ agonist LY465606 in brachiocephalic arteries of mice treated for 4 weeks and in ligated carotid arteries of animals treated for 2 weeks. Reduction in CE and FC accumulation in atherosclerotic lesions was associated with the reduction of lesion size. Thus, a combination of LC/MS/MS measurements of CE and FC followed by histology and immunohistochemistry of the same tissue provides novel methodology for sensitive and comprehensive analysis of experimental atherosclerotic lesions. Sensitive method for chemical analysis of free cholesterol (FC) and cholesterol esters (CE) was developed. Mouse arteries were dissected and placed in chloroform-methanol without tissue grinding. Extracts underwent hydrolysis of cholesteryl esters and derivatization of cholesterol followed by liquid chromatography/mass spectrometry (LC/MS/MS) analysis. We demonstrated that FC and CE could be quantitatively extracted without tissue grinding and that lipid extraction simultaneously worked for tissue fixation. Delipidated tissues can be embedded in paraffin, sectioned, and stained. Microscopic images obtained from delipidated arteries have not revealed any structural alterations. Delipidation was associated with excellent antigen preservation compatible with traditional immunohistochemical procedures. In ApoE−/− mice, LC/MS/MS revealed early antiatherosclerotic effects of dual PPARα,γ agonist LY465606 in brachiocephalic arteries of mice treated for 4 weeks and in ligated carotid arteries of animals treated for 2 weeks. Reduction in CE and FC accumulation in atherosclerotic lesions was associated with the reduction of lesion size. Thus, a combination of LC/MS/MS measurements of CE and FC followed by histology and immunohistochemistry of the same tissue provides novel methodology for sensitive and comprehensive analysis of experimental atherosclerotic lesions. Atherosclerosis is a primary cause of heart attack and hence represents the major area of basic research as well as a drug-discovery focus (1.Meng C.Q. A new era in atherosclerosis drug discovery.Expert Rev. Cardiovasc. Ther. 2004; 2: 633-636Crossref PubMed Scopus (4) Google Scholar). Wide application of genetically modified mice (2.Zadelaar S. Kleemann R. Verschuren L. de Vries-Van der Weij J. van der Hoorn J. Princen H.M. Kooistra T. Mouse models for atherosclerosis and pharmaceutical modifiers.Arterioscler. Thromb. Vasc. Biol. 2007; 27: 1706-1721Crossref PubMed Scopus (436) Google Scholar) demands development of quantitative analytical endpoints. Conventionally, atherosclerotic burden in mouse models is evaluated by aortic planimetry (3.Nakashima Y. Plump A.S. Raines E.W. Breslow J.L. Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.Arterioscler. Thromb. 1994; 14: 133-140Crossref PubMed Google Scholar, 4.Teupser D. Persky A.D. Breslow J.L. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement).Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1907-1913Crossref PubMed Scopus (133) Google Scholar, 5.Daugherty A. Pure E. Delfel-Butteiger D. Chen S. Leferovich J. Roselaar S.E. Rader D.J. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E−/− mice.J. Clin. Invest. 1997; 100: 1575-1580Crossref PubMed Scopus (227) Google Scholar, 6.Mach F. Schonbeck U. Sukhova G.K. Atkinson E. Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.Nature. 1998; 394: 200-203Crossref PubMed Scopus (803) Google Scholar). Aortic lesions, however, take several months to develop, which significantly hampers utility of this analysis, especially in drug discovery. Early atherosclerosis can be detected in specific locations (e.g., aortic root and brachiocephalic arteries) (3.Nakashima Y. Plump A.S. Raines E.W. Breslow J.L. Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.Arterioscler. Thromb. 1994; 14: 133-140Crossref PubMed Google Scholar, 7.VanderLaan P.A. Reardon C.A. Getz G.S. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators.Arterioscler. Thromb. Vasc. Biol. 2004; 24: 12-22Crossref PubMed Scopus (463) Google Scholar). However, quantification of early lesions is largely limited to histology (8.Rattazzi M. Bennett B.J. Bea F. Kirk E.A. Ricks J.L. Speer M. Schwartz S.M. Giachelli C.M. Rosenfeld M.E. Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells.Arterioscler. Thromb. Vasc. Biol. 2005; 25: 1420-1425Crossref PubMed Scopus (135) Google Scholar, 9.Bea F. Blessing E. Bennett B. Levitz M. Wallace E.P. Rosenfeld M.E. Simvastatin promotes atherosclerotic plaque stability in ApoE-deficient mice independently of lipid lowering.Arterioscler. Thromb. Vasc. Biol. 2002; 22: 1832-1837Crossref PubMed Scopus (135) Google Scholar), because, due to their small size, the amount of available tissue is often insufficient for biochemical analyses. Similar analytical challenges are typical to various models of accelerated atherosclerosis, where disease process is stimulated by local hemodynamic or mechanical factors in the carotid or femoral arteries (10.Sasaki T. Kuzuya M. Nakamura K. Cheng X.W. Shibata T. Sato K. Iguchi A. A simple method of plaque rupture induction in apolipoprotein E-deficient mice.Arterioscler. Thromb. Vasc. Biol. 2006; 26: 1304-1309Crossref PubMed Scopus (101) Google Scholar, 11.Ivan E. Khatri J.J. Johnson C. Magid R. Godin D. Nandi S. Lessner S. Galis Z.S. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions.Circulation. 2002; 105: 2686-2691Crossref PubMed Scopus (99) Google Scholar, 12.Lardenoye J.H.P. Delsing D.J.M. de Vries M.R. Deckers M.M.L. Princen H.M.G. Havekes L.M. van Hinsbergh V.W.M. van Bockel J.H. Quax P.H.A. Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3 leiden transgenic mice.Circ. Res. 2000; 87: 248-253Crossref PubMed Scopus (66) Google Scholar). Development of highly sensitive and robust methodology is needed for fast and accurate analysis of these small lesions. Chromatography coupled with mass spectrometry is a powerful methodology for analysis of biological samples. Combined liquid chromatography/mass spectrometry (LC/MS) has been increasingly found to be method of choice over GC/MS for many reasons. Chief among them are the ease of method development and higher throughput of the former method. However, analysis of free cholesterol (FC) and cholesterol esters (CE) in biological matrix is a major exception. To date, there are far fewer LC/MS methods than GC/MS methods for analysis of FC and CE. One major contributing factor is that the ionization of cholesterol under normal LC elution conditions is much less favorable than the GC/MS method, which utilizes electron impact. Recently, there are a few reports of measuring cholesterol and its oxides by LC-atmosphere pressure chemical ionization (APCI)-MS method (13.Raith K. Brenner C. Farwanah H. Muller G. Eder K. Neubert R.H.H. A new LC/APCI-MS method for the determination of cholesterol oxidation products in food.J. Chromatogr. A. 2005; 1067: 207-211Crossref PubMed Scopus (63) Google Scholar, 14.Sandhoff R. Brügger B. Jeckel D. Lehmann W. Wieland F. Determination of cholesterol at the low picomole level by nano- electrospray ionization tandem mass spectrometry.J. Lipid Res. 1999; 40: 126-132Abstract Full Text Full Text PDF PubMed Google Scholar, 15.Liebisch G Binder M Schifferer R Langmann T Schulz B Schmitz G High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI- MS/MS) Biochimica et Biophysics Acta (BBA). 2006; 1761: 121-128Google Scholar). However, these techniques are not directly applicable to analysis of mouse atherosclerosis due to limited sensitivity and inability to measure CE. In this paper, we describe a sensitive LC/MS-based technique facilitating simultaneous, independent quantification of FC and CE in the small arteries. Another major challenge in quantification of mouse atherosclerosis is that biochemical and morphological data are usually derived from different vascular beds within the same animal or from separate mice. We sought to develop a methodology that would facilitate gathering chemical (FC and CE) and morphological data from the same sample. We demonstrated that CE and FC could be quantitatively extracted from mouse arteries without tissue grinding and that lipid extraction simultaneously works for tissue fixation. Microscopic images obtained from delipidated arteries have not revealed any structural alterations. Delipidation was associated with excellent antigen preservation compatible with traditional immunohistochemical procedures. In this paper, we provide detailed description of a technique and demonstrate its utility for drug discovery. Cholesterol, cholesterol-2,2,3,4,4,6-2H6, pentafluorophenyl isocyanate (PFPI), and stearoyl chloride were purchased from Aldrich (Milwaukee, WI). Cholesterol-3,4-13C2 was purchased from Medical Isotopes Inc. (Pelham, NH). Sodium methoxide in methanol was also purchased form Aldrich. Solvents used for LC/MS were HPLC grade. Solvents used for extraction and sample preparation were either HPLC or reagent grade. All reagents were used as received. 3,4-13C2-cholesteryl stearate was synthesized as described by Swell (16.Swell L. Treadwell C.R. Cholesterol esterases. VI. Relative specificity and activity of pancreatic cholesterol esterase.J. Biol. Chem. 1955; 212: 141-150Abstract Full Text PDF PubMed Google Scholar). In a 2-ml vial, 32.7 mg (0.084 mmol) of cholesterol-3,4-13C2 were weighed. A quantity of hexane just sufficient to wet the crystals was added followed by 40 μl (0.118 mmol) of stearoyl chloride. The mixture was warmed on a hot plate for a few minutes, and 7.0 μl (0.087 mmol) of dry pyridine were added. The mixture was heated at 80°C for 30 min. After 30 min the product was dissolved in a minimum amount of hot acetone and isolated by recrystallization. Experimental procedures using animals were approved by the Institutional Animal Care and Use Committee and performed in accordance with the Guide for the Care and Use of Laboratory Animals. Eight-week-old ApoE−/− mice were obtained from Taconic (Hudson, NY). The animals (n = 10–12 per group) were fed with Western diet containing 0.21% cholesterol, and 21% fat. Plasma lipids were analyzed on a Roche/Hitachi automatic analyzer 912 (Roche Diagnostics, Indianapolis, IN), and total cholesterol was used for animal randomization. To analyze early spontaneous atherosclerosis, the mice were euthanized 28 days after the beginning of Western diet feeding, and brachiocephalic arteries were dissected. To accelerate lesion formation, ApoE−/− mice were prefed with the Western diet for 14 days, and then their left common carotid arteries were ligated under isofluorane anesthesia as described previously (11.Ivan E. Khatri J.J. Johnson C. Magid R. Godin D. Nandi S. Lessner S. Galis Z.S. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions.Circulation. 2002; 105: 2686-2691Crossref PubMed Scopus (99) Google Scholar). Mice were kept on the same diet following the ligation surgery and were euthanized 14 days after ligation. Ligated and unligated (contralateral) common carotid arteries were dissected. To assess the utility of our new analytical approach to drug discovery, the animals were treated with the dual PPARα,γ agonist LY465606 at the dose 10 mg/kg/d by oral gavage as described previously (17.Zuckerman S. Kauffman R. Evans G. Peroxisome proliferator-activated receptor α,γ coagonist LY465608 inhibits macrophage activation and atherosclerosis in apolipoprotein E knockout mice.Lipids. 2002; 37: 487-494Crossref PubMed Scopus (34) Google Scholar). Control mice received vehicle solution (1% CMC, 0.25% Tween 80, Fisher Scientific, Fair Lawn, NJ). Drug effects were tested in early spontaneous lesions (brachiocephalic artery) and in accelerated lesions (carotid ligation). Two methods of extracting cholesterol and its esters from arterial tissue were employed. In the first method, cholesterol and cholesterol ester were extracted from the arterial tissue by the method of Folch (18.Folch J. Lees M. Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues.J. Biol. Chem. 1957; 226: 497-509Abstract Full Text PDF PubMed Google Scholar). Tissue samples were transferred to Potter-Elvehjem type tissue grinders containing 0.5 ml of 2:1 chloroform/methanol and appropriate amounts of cholesterol- 2,2,3,4,4,6-d6 and 3,4-13C2-cholesteryl stearate. Tissue samples were macerated manually until complete emulsification was observed. After maceration the pestle was rinsed with 0.5 ml of 2:1 chloroform/methanol, the 1.0 ml extract was transferred to a screw cap vial, and the tissue grinder was rinsed with an additional 0.5 ml of 2:1 chloroform/methanol. The rinsings were added to the vial to give a total of 1.5 ml of extract. Then 0.3 ml of water were added to the vial, and after vigorous shaking, the layers were allowed to separate on standing. After separation, the top layer was removed, along with any interfacial solid material, by siphoning with a pipet. The lower layer was then divided into two aliquots of equal volume, one aliquot to be used for FC determination and the second for total cholesterol determination after hydrolysis of cholesteryl esters. Each aliquot was placed in a 2-ml autosampler vial and then evaporated to dryness in preparation for hydrolysis and/or derivatization. In the second method, tissue samples were immersed in 1 to 3 ml of 2:1 chloroform/methanol. After standing >16 h the tissue sample was removed from the extraction solvent. Appropriate amounts of cholesterol- 2,2,3,4,4,6-d6 and 3,4-13C2-cholesteryl stearate internal standards were added and two 100-μl aliqouts were taken. Each aliquot was placed in a 2-ml autosampler vial and then evaporated to dryness in preparation for hydrolysis and/or derivatization. To test the completeness of lipid extraction from the whole artery, we measured cholesterol and CE in the extracts obtained after incubation of the intact artery in chloroform-methanol (previously referred to as a second method), then reextracted already delipidated arteries using classical Folch technique (previously referred to as a the first method). Three hundred μl of dry tetrahydrofuran and 30 μl of a 25 weight % solution of sodium methoxide in methanol were added to the dried aliquot designated for hydrolysis. The vial was capped and heated at 60°C for 30 min. After 30 min, 10 μl of glacial acetic acid were added, and the sample was evaporated to dryness. One ml of hexane and 0.2 ml water were added. The mixture was shaken vigorously and the layers were allowed to separate. Then 0.9 ml of the hexane layer were removed and derivatized. One ml of hexane was added to the dried extract, which was not hydrolyzed. Derivatization of the hexane solutions was effected by addition of 3 μl pyridine and 5 μl of PFPI. The reaction was allowed to proceed at room temperature for 10 minutes, during which time a white precipitate formed. After 10 minutes 100 μl of isopropanol was added to each vial, which redissolved the precipitate. The cholesterol-d6 and cholesterol-13C2 internal standard solutions were made up in toluene at 0.2 mg/ml and 0.3 mg/ml respectively. A 1 to 10 dilution of the cholesterol-2H6 solution was prepared for spiking calibration standards. For the purpose of calibration, a stock solution of cholesterol was made up in toluene at 0.2 mg/ml. Calibration standards were prepared by diluting this solution and adding appropriate amounts of internal standard. The solution was then derivatized. Derivatized extracts prepared by the first method were run on a Quattro LC (Waters Corporation, Milford, MA; Micromass, Waters Corporation, Milford, MA) triple quadrupole mass spectrometer, equipped with a Shimadzu HPLC system (Shimadzu Scientific Instruments, Columbia, MD) comprising two LC-10ADvp pumps and an SCL-10Avp controller. Sample separation was effected by a normal phase isocratic method using an YMC-pack SIL column (150 × 4.6 mm, 5 μm, Waters). The mobile phase was 90/10 hexane/isopropanol at 1.0 ml/min. Ionization was effected by APCI in the negative mode using the following source parameters: corona pin, 3.0kV; cone, 40V; extractor, 0V; source block, 150C; probe, 350C; desolvation gas, 457L/hr. Detection was by multiple reaction monitoring (MRM). The transitions monitored were 595.4→206.0, 597.4→206.0, and 601.5→206.0 corresponding to cholesterol, cholesterol-13C2, and cholesterol-d6, respectively. The collision energy was 60V and the collision cell pressure was 7.0 × 10−4 mbar. Derivatized extracts prepared by the second method were run on a Thermofinnigan Quantum triple quadrupole mass spectrometer (Thermo Fisher Scientific, Inc. Waltham, MA), equipped with an Agilent 1100 series HPLC system (Agilent Technologies, Santa Clara CA) comprising a binary pump, a wellplate autosampler, and column heater. Sample separation was effected by a normal phase gradient method using a 2.0 × 150 mm YMC silica column, 3 μm particle size (Waters Corporation, Milford, MA). Eluant A was 95/5 hexane/isopropanol, and eluant B was isopropanol containing 0.1% acetic acid. The gradient is shown in Table 1 . Ionization was effected by atmosphere pressure chemical ionization (APCI) in the negative mode using the following source parameters: discharge current 55 μA, vaporizer temperature 200°C, sheath gas 80, ion sweep gas 0, auxillary gas 30, ion transfer capillary 225°C. Collisonally activated decomposition was accomplished using argon @ 1.5 and a collision energy of 30 V.TABLE 1.HPLC gradient conditionsTime, minFlow Rate, ml/minComposition0.00.25100% A 0% B2.00.25100% A 0% B2.50.6010% A 90% B5.00.6010% A 90% B5.50.60100% A 0% B9.50.60100% A 0% B10.00.25100% A 0% BIonization was effected by atmosphere pressure chemical ionization (APCI) in the negative mode using the following source parameters: discharge current 55 μA, vaporizer temperature 200°C, sheath gas 80, ion sweep gas 0, auxillary gas 30, ion transfer capillary 225°C. Collisonally activated decomposition was accomplished using argon @ 1.5 and a collision energy of 30 V. Open table in a new tab Ionization was effected by atmosphere pressure chemical ionization (APCI) in the negative mode using the following source parameters: discharge current 55 μA, vaporizer temperature 200°C, sheath gas 80, ion sweep gas 0, auxillary gas 30, ion transfer capillary 225°C. Collisonally activated decomposition was accomplished using argon @ 1.5 and a collision energy of 30 V. For conventional histology, the mice were perfused with saline and then with eather 4% formalin or IHC Zink fixative (BD Pharmingen, San Diego, CA) via left ventricle. Brachiocephalic or common carotid arteries were dissected, immersed in the respective fixative for 24 h and paraffin embedded. To enable novel approach of sequestial lipid and histological analysis, the mice were perfused with saline via the left ventricle, the arteries were dissected and placed into 1 ml of 2:1 chloroform/methanol solution. After standing >16 h the tissue sample was removed from the extraction solvent. The solvent was utilized for cholesterol analysis, while delipidated vessels were paraffin embedded. To explore potential influence of prolonged delipidation on the tissue antigen preservation, several vessels we kept in the solvent solution up to 7 days and then paraffin embedded. For histology, 10 equally spaced (200 μm) paraffin cross-sections were stained using modified Masson's trichrome (Sigma, St. Louis, MO) procedure that included elasin staining. Macrophages were visualized immunohistochemically using MAC-2 antibody (clone M3/38, Cedarlane Laboratories, Burlington, Ontario). Sections were incubated for 30 min at room temperature. After primary antibody incubation, sections were incubated with biotinylated rabbit anti-rat IgG (Vector Laboratories, Burlingame, CA), followed by streptavidan-biotin complex (DAKO, Carpinteria, CA) and development with diaminobenzidine. Rat IgG staining was used as negative control. For smooth muscle cell visualization, α-smooth muscle actin EPOS (DAKO) was utilized. Sections were incubated for 60 min at room temperature followed by development with diaminobenzidine. The lesion area, defined as an area between the lumen and internal elastic lamina, was calculated using Image-Pro Plus Version 5.0.1 (Media Cybernetics, Inc, Bethesda, MD). The results are shown as the mean ± SEM. Differences between groups were determined using one-way ANOVA with posthoc Dunnett's t-test. A value of P < 0.05 was regarded as a significant difference. The reaction product of PFPI and cholesterol was examined by LC/MS using full mass range acquisition (m/z 100–800). In addition to the cholesterol derivative, we observed the isopropyl carbamate of PFPI as well as products do due to reaction with water. The negative ion spectrum corresponding to the reaction product is shown in Fig. 1A . The molecular radical-anion is observed at m/z 595. A peak at m/z 594 probably arises from ionization by proton abstraction. The peak at m/z 576 corresponds to loss of a fluorine radical from the molecular radical anion, while the peak at m/z 367 corresponds to the elimination of pentafluorophenyl carbamic acid from the m/z 594 ion. Other observed byproducts from this reaction are isopropyl pentaflourophenyl carbamate, the biuret of PFPI, and the urea of PFPI (Fig. 1A, C, D). Thus, the only reaction product with cholesterol is the expected derivative. Product ion experiments were performed on the cholesteryl carbamate in order to determine the most appropriate transitions for MRM experiments. Samples of cholesterol and cholesterol-d6 were derivatized and infused into the APCI source of the Quattro LC triple quadupole MS. Product ion spectra derived from the molecular radical anions at m/z 595 and 601 are shown in Fig. 2 . These compounds produce few fragments with the largest at m/z 206 in each case. Although not shown, the PFPI derivative of cholesterol-3,4-13C2 also produces this fragment in the same relative abundance. This fragment is dominant at all collision energies tested. Its mass, 206, corresponds to loss of the hydrocarbon portion of the molecule and a molecule of HF from the molecular radical anion (595– 69–20 = 206), suggesting that the fragment's elemental formula is C7F4NO2. A structure having this formula and a plausible mechanism for its formation are shown in Figure 3 . Based on this information MRM transitions from M+ · → m/z 206 were chosen for quantitative analysis. In order to confirm that the response of cholesterol is equal to the response of cholesterol-d6, calibration solutions were made by diluting a cholesterol stock solution over the range 0.05–450 nmol/ml. An aliquot of 0.510 nmol of cholesterol-d6 were added to each and the solutions were derivatized as previously described. Fig. 4 shows a log/log plot of the results. The plot is linear over four orders of magnitude, with a slope close to one.Fig. 3.Mechanism of formation of m/z 206 fragment from PFPI derivative of cholesterol.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Fig. 4.Calibration curve. Area cholesterol/area cholesterol-d6 vs. moles cholesterol/moles cholesterol-d6.View Large Image Figure ViewerDownload Hi-res image Download (PPT) To assess the accuracy of the method, solutions containing known amounts of cholesterol and cholesterol stearate were prepared in extraction solvent. The range of concentrations was chosen based on the range of analytes observed in preliminary experiments. Internal standards were added and the solutions were subjected to the assay as described above. The amount of cholesterol found was calculated by assuming that the response ratios between each analyte and its labeled internal standard were one. The results are shown in Figures 5 and 6. Neither slope is significantly different from one, indicating the amount found is equal to the amount taken. The coefficient of variation of the mean response was found to be 3%. From these data we concluded that the method is sufficiently accurate and precise to determine the amounts of FC and CE in mouse brachiocephalic or carotid arteries.Fig. 6.Method accuracy for cholesterol ester.View Large Image Figure ViewerDownload Hi-res image Download (PPT) The method employs two differently labeled internal standards, 2H6-cholesterol and 13C2-cholesterol ester, which allows us to correct for: (a) the isotopic enrichment of naturally occurring 13C's, (b) the incomplete hydrolysis of the ester under the experimental condition, (c) detector response and sample volume variations between injections for each pair of samples, and (d) calibration standards for FC and total cholesterol. After the addition of the two ISTDs the samples are divided in half; one half is then subjected to total hydrolysis. The unhydrolyzed sample is used to determine the FC while the hydrolyzed sample represents the total cholesterol. The data analysis of the FC is straightforward as the cholesterol area is calibrated against the cholesterol-2H6 internal standard in the unhydrolyzed sample. To calculate the esterified cholesterol, we used data from both sets of samples. The ratio of (M+2)/M ratio of the derivatized cholesterol peak in the unhydrolyzed sample is used to correct for the naturally occurring C13 isotope contributions to the C13 labeled internal standard ion observed in the hydrolyzed sample. This corrected area represents the response of the 13C2 labeled IS. The cholesterol/cholesterol-2H6 ratio in the hydrolyzed sample is then used to correct the total cholesterol peak area, observed in the hydrolyzed sample for the amount of FC observed in the unhydrolyzed sample. This corrects for the volume loss during hydrolysis and possible detector response variation between injections. The cholesterol ester area is then ratioed against the corrected cholesterol-13C2 area to determine the amount of cholesterol ester. This corrects for losses due to incomplete hydrolysis. We have found that this method allows us to estimate the free and total CE in a precise manner. Prior to the broad application of described chemical analysis to specific drug discovery projects, we decided to optimize and simplify lipid extraction procedure. Specifically, we hypothesized that the lipids can be effectively extracted from the intact whole artery without tissue grinding. FC and CE were measured in the extracts obtained after incubation of the intact carotid artery in chloroform-methanol. Subsequently, already delipidated arteries were reextracted using classical Folch technique that involved grinding of the previously extracted tissues. Examination of 15 samples revealed that only 2.04 ± 1.88% of FC and 1.22 ± 0.98% of CE remained in the tissue after the first extraction thus confirming near complete lipid extraction from the whole artery. Hence, the whole artery extraction was used in the further studies. FC and CE content was dramatically increased in BCA after 28 days of Western diet feeding that is consistent with the time course of atherosclerotic plaque formation. LY465608 treatment significantly reduced FC and CE accumulation thus revealing its antiatherosclerotic activity in the early vascular lesions (Fig. 7A and B). Similar analysis performed on the extracts from the left (ligated) and right (unligated) common carotid arteries in the flow cessation model of accelerated atherosclerosis demonstrated that FC and CE preferentially accumulated in the ligated arteries 14 days after ligation (Fig. 7C and D). It is consistent with the vascular lesion development in association with the blood flow cessation. In this model as well, LY465608 significantly inhibited FC and CE accumulation in lesions. Thus, LC/MS measurements provided required sensitivity to detect early antiatherosclerotic effect" @default.
• W2008990589 created "2016-06-24" @default.
• W2008990589 creator A5003181368 @default.
• W2008990589 creator A5027548267 @default.
• W2008990589 creator A5032725637 @default.
• W2008990589 creator A5032819724 @default.
• W2008990589 creator A5035779733 @default.
• W2008990589 creator A5044520771 @default.
• W2008990589 creator A5047992426 @default.
• W2008990589 creator A5048372050 @default.
• W2008990589 creator A5088182005 @default.
• W2008990589 date "2008-06-01" @default.
• W2008990589 modified "2023-09-27" @default.
• W2008990589 title "Chemical analysis of atherosclerotic plaque cholesterol combined with histology of the same tissue" @default.
• W2008990589 cites W188650391 @default.
• W2008990589 cites W1964814612 @default.
• W2008990589 cites W1974556160 @default.
• W2008990589 cites W2000119134 @default.
• W2008990589 cites W2000273878 @default.
• W2008990589 cites W2031848120 @default.
• W2008990589 cites W2055188374 @default.
• W2008990589 cites W2070820319 @default.
• W2008990589 cites W2070834812 @default.
• W2008990589 cites W2105924650 @default.
• W2008990589 cites W2123353784 @default.
• W2008990589 cites W2125001301 @default.
• W2008990589 cites W2125674758 @default.
• W2008990589 cites W2128738849 @default.
• W2008990589 cites W2132228452 @default.
• W2008990589 cites W2133586454 @default.
• W2008990589 cites W2133866061 @default.
• W2008990589 cites W2135125881 @default.
• W2008990589 cites W2137530145 @default.
• W2008990589 cites W2146042164 @default.
• W2008990589 cites W2156811410 @default.
• W2008990589 cites W2157904413 @default.
• W2008990589 cites W2168526937 @default.
• W2008990589 cites W2185275183 @default.
• W2008990589 cites W2886042269 @default.
• W2008990589 doi "https://doi.org/10.1194/jlr.d700037-jlr200" @default.
• W2008990589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18349418" @default.
• W2008990589 hasPublicationYear "2008" @default.
• W2008990589 type Work @default.
• W2008990589 sameAs 2008990589 @default.
• W2008990589 citedByCount "14" @default.
• W2008990589 countsByYear W20089905892012 @default.
• W2008990589 countsByYear W20089905892014 @default.
• W2008990589 countsByYear W20089905892015 @default.
• W2008990589 countsByYear W20089905892018 @default.
• W2008990589 crossrefType "journal-article" @default.
• W2008990589 hasAuthorship W2008990589A5003181368 @default.
• W2008990589 hasAuthorship W2008990589A5027548267 @default.
• W2008990589 hasAuthorship W2008990589A5032725637 @default.
• W2008990589 hasAuthorship W2008990589A5032819724 @default.
• W2008990589 hasAuthorship W2008990589A5035779733 @default.
• W2008990589 hasAuthorship W2008990589A5044520771 @default.
• W2008990589 hasAuthorship W2008990589A5047992426 @default.
• W2008990589 hasAuthorship W2008990589A5048372050 @default.
• W2008990589 hasAuthorship W2008990589A5088182005 @default.
• W2008990589 hasBestOaLocation W20089905891 @default.
• W2008990589 hasConcept C142724271 @default.
• W2008990589 hasConcept C185592680 @default.
• W2008990589 hasConcept C2778163477 @default.
• W2008990589 hasConcept C55493867 @default.
• W2008990589 hasConcept C57742111 @default.
• W2008990589 hasConcept C71924100 @default.
• W2008990589 hasConceptScore W2008990589C142724271 @default.
• W2008990589 hasConceptScore W2008990589C185592680 @default.
• W2008990589 hasConceptScore W2008990589C2778163477 @default.
• W2008990589 hasConceptScore W2008990589C55493867 @default.
• W2008990589 hasConceptScore W2008990589C57742111 @default.
• W2008990589 hasConceptScore W2008990589C71924100 @default.
• W2008990589 hasIssue "6" @default.
• W2008990589 hasLocation W20089905891 @default.
• W2008990589 hasOpenAccess W2008990589 @default.
• W2008990589 hasPrimaryLocation W20089905891 @default.
• W2008990589 hasRelatedWork W1480599264 @default.
• W2008990589 hasRelatedWork W1966846596 @default.
• W2008990589 hasRelatedWork W2000146891 @default.
• W2008990589 hasRelatedWork W2142971390 @default.
• W2008990589 hasRelatedWork W2398260538 @default.
• W2008990589 hasRelatedWork W2408693058 @default.
• W2008990589 hasRelatedWork W2555652867 @default.
• W2008990589 hasRelatedWork W2748952813 @default.
• W2008990589 hasRelatedWork W2899084033 @default.
• W2008990589 hasRelatedWork W4290146107 @default.
• W2008990589 hasVolume "49" @default.
• W2008990589 isParatext "false" @default.
• W2008990589 isRetracted "false" @default.
• W2008990589 magId "2008990589" @default.
• W2008990589 workType "article" @default.